Advertisement

Topics

Intranasal Therapeutics, Inc. Company Profile

01:40 EST 18th November 2017 | BioPortfolio

Intranasal Therapeutics, Inc. (ITI) is a specialty pharmaceutical company focused on developing innovative nasally delivered pharmaceutical products, with a particular focus on drugs treating pain and disorders related to the central nervous system for which there is proven, unsatisfied consumer need. We currently have four products in our pipeline, with several others in formulation or preclinical development.
Our goal is to become a leader in the field of intranasal pharmaceuticals by applying our formulation expertise across a broad range of therapeutic areas to create new and differentiated products that improve safety, efficacy and convenience for patients, caregivers and health care professionals.

ITI’s fully integrated nasal drug delivery platform combines proprietary formulation research, clinical and regulatory development, specialized delivery systems, sterile manufacturing and packaging of nasal products. These capabilities and expertise enable us to develop our products efficiently and cost effectively. We will

Location

1513 Bull Lea Blvd.
Lexington
Kentucky
40511
United States of America

Contact

Phone: 859.252.5080
Fax: 859.252.7280
Email: info@intranasal.com


News Articles [559 Associated News Articles listed on BioPortfolio]

INSYS Therapeutics Completes Pharmacokinetics (PK) Study of Intranasal Naloxone for Opioid Overdose

PHOENIX, Oct. 03, 2017 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”), announced today that its recently completed pharmacokinetics (PK) study of th...

Noninvasive intranasal method shows prevention of neurologic effect from metabolic disease

(Mary Ann Liebert, Inc./Genetic Engineering News) Researchers have successfully used a noninvasive intranasal approach to deliver the gene for the enzyme that is deficient in the inherited lysosomal s...

Global Intranasal Drug Delivery Device Market Research Report Forecast 20172022 [Report Updated: 01072017] Prices from USD $2800

Delivery of the Report will take 4872 hours once order is placed.The Global Intranasal Drug Delivery Device Market Research Report Forecast 20172022 is a valuable source of insightful data for busine...

Global Intranasal Drug Delivery Device Market Research Report Forecast 20172022 [Report Updated: 18092017] Prices from USD $2800

Delivery of the Report will take 4872 hours once order is placed.The Global Intranasal Drug Delivery Device Market Research Report Forecast 20172022 is a valuable source of insightful data for busine...

Global Intranasal Drug Delivery Devices Market Research Report Forecast 20172022 [Report Updated: 18062017] Prices from USD $2800

Delivery of the Report will take 4872 hours once order is placed.The Global Intranasal Drug Delivery Devices Market Research Report Forecast 20172022 is a valuable source of insightful data for busin...

Global Intranasal Drug Delivery Devices Market Research Report Forecast 20172022 [Report Updated: 18092017] Prices from USD $2800

Delivery of the Report will take 4872 hours once order is placed.The Global Intranasal Drug Delivery Devices Market Research Report Forecast 20172022 is a valuable source of insightful data for busin...

Impel NeuroPharma Names Jon Congleton President and CEO

Jon Congleton has been named president and CEO of Seattle-based Impel NeuroPharma. Congleton was most recently president and CEO of Nivalis Therapeutics in Boulder, CO. Impel is developing intranasal ...

Flu Season Is Going to be Painful for Some

CDC recommends against intranasal flu vaccine.

PubMed Articles [516 Associated PubMed Articles listed on BioPortfolio]

Randomized Controlled Feasibility Trial of Intranasal Ketamine Compared to Intranasal Fentanyl for Analgesia in Children with Suspected Extremity Fractures.

We compared the tolerability and efficacy of intranasal sub-dissociative ketamine to intranasal fentanyl for analgesia of children with acute traumatic pain and investigated the feasibility of a large...

Median effective dose of intranasal dexmedetomidine sedation for transthoracic echocardiography in pediatric patients with noncyanotic congenital heart disease: An up-and-down sequential allocation trial.

Intranasal dexmedetomidine can provide adequate sedation during short procedures. However, previous literature investigating the single-dose use of intranasal dexmedetomidine for sedation during trans...

Intranasal pitavastatin attenuates seizures in different experimental models of epilepsy in mice.

This study was carried out to evaluate the effect of intranasal pitavastatin (PVS) on pentylenetetrazole (PTZ)-induced seizures, increasing current electroshock (ICES) seizures, and status epilepticus...

Pharmacokinetics of α-asarone after intranasal and intravenous administration with PLA-α-asarone nanoparticles.

PLA-α-asarone nanoparticles were prepared by using organic solvent evaporation method, and their in vivo distribution and brain targeting after intranasal administration were studied as compared with...

Intranasal sumatriptan for acute migraine attacks: a systematic review and meta-analysis.

We performed this systematic review and meta-analysis to evaluate the tolerability and efficacy of intranasal sumatriptan, a selective serotonin agonist, compared to placebo or other migraine therapeu...

Clinical Trials [420 Associated Clinical Trials listed on BioPortfolio]

Effect of Intranasal Anti-IgE Antibodies on IgE Production

In this study, participants will receive either intranasal anti-IgE-antibodies (n=5) or intranasal allergen (n=5) or intranasal placebo (n=5). Blood samples will be obtained before nasal a...

Efficacy and Safety of Intranasal Morphine for Pain After Bunion Surgery

Study designed to evaluate the efficacy and safety of Intranasal (IN) Morphine Nasal Spray (MNS075) 3.75 mg, 7.5 mg, 15 mg, and 30 mg, intravenous (IV) morphine 7.5 mg, or IN placebo in pa...

Effects of Intranasal Oxytocin and Vasopressin on Social Behavior and Decision Making

The purpose of this study is to investigate the role of a one-time intranasal administration of the oxytocin, vasopressin, or placebo on prosocial decision making such as cooperation and c...

Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers

To determine the pharmacokinetics of 4 intranasal doses of naloxone compared to a 0.4 mg dose of naloxone administrated intramuscular and to identify an appropriate intranasal dose that co...

IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D

The general objective of this study is to determine whether intranasal ketamine should be incorporated into formulary as an option to treat pain during minor procedures in the pediatric em...

Companies [1192 Associated Companies listed on BioPortfolio]

Intranasal Therapeutics, Inc.

Intranasal Therapeutics, Inc. (ITI) is a specialty pharmaceutical company focused on developing innovative nasally delivered pharmaceutical products, with a particular focus on drugs treating pain and...

Tarsa Therapeutics, Inc.

Tarsa Therapeutics is developing an oral formulation of calcitonin, a peptide hormone for the treatment of osteoporosis that inhibits bone resorption, the process underlying osteoporosis. Availabilit...

Cyrano Therapeutics, Inc.

Cyrano Therapeutics, Inc. is a United States based pharmaceutical company developing therapeutic solutions for olfactory dysfunction, a condition that limits the ability to taste ...

NanoBio Corp.

NanoBio® Corporation is a privately-held biopharmaceutical company focused on developing and commercializing dermatological products, anti-infective treatments and intranasal v...

Impel NeuroPharma, Inc.

Impel NeuroPharma, Inc. is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel NeuroPharma has developed a novel drug d...

More Information about "Intranasal Therapeutics, Inc." on BioPortfolio

We have published hundreds of Intranasal Therapeutics, Inc. news stories on BioPortfolio along with dozens of Intranasal Therapeutics, Inc. Clinical Trials and PubMed Articles about Intranasal Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Intranasal Therapeutics, Inc. Companies in our database. You can also find out about relevant Intranasal Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record